Inactive Instrument

Aker BioMarine AS Share Price Oslo Bors

Equities

NO0010886625

Fishing & Farming

Financials

Sales 2024 * 4.31B 397M 31.6B Sales 2025 * 4.6B 423M 33.68B Capitalization 6.18B 568M 45.27B
Net income 2024 * 189M 17.38M 1.38B Net income 2025 * 212M 19.5M 1.55B EV / Sales 2024 * 2.24 x
Net Debt 2024 * 3.48B 320M 25.51B Net Debt 2025 * 3.51B 323M 25.72B EV / Sales 2025 * 2.11 x
P/E ratio 2024 *
33.4 x
P/E ratio 2025 *
29.7 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 13.09%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 48 31/12/08
Director of Finance/CFO 47 31/07/18
Human Resources Officer - 30/04/16
Members of the board TitleAgeSince
Director/Board Member 54 31/12/94
Director/Board Member 64 31/12/20
Chairman 47 31/12/13
More insiders
Aker Biomarine ASA is a Norway-based biotech innovator and Antarctic krill-harvesting company. It consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarine’s focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.
Calendar
More about the company